No Slide Title

Download Report

Transcript No Slide Title

Science, research and development
European Commission
Warsaw conference launching the 6th
Framework Programme of the
European Union
Etienne Magnien
Research DG, European Commission
Warsaw, 25-26 November 2002
Science, research and development
European Commission
Community Research Programmes
•
Objectives (Article 163 Amsterdam Treaty)
– to strengthen the European research potential
– to promote the competitiveness of European industry
– to support Community policies
• From FP V (1998-2002)
to ERA and FP VI (2003-2006)
Society’s Needs
Integrating European Research
Key Actions
RDT
Generic Activities
Support for Infrastructure
Problem-solving Approach
Priority Thematic Areas
Structuring the
ERA
Anticipating S/T Needs
Strengthening the
Foundations of ERA
Towards a European Research Policy
Science, research and development
European Commission
Programme Structure and Budgetary
Distribution
(i) 6 Key Actions :
- Food, nutrition & health
MEURO
290
- Control of infectious diseases
300
- The cell factory
400
- Environment and health
160
- Sustainable agriculture, fisheries and forestry, and integrated
development of rural areas including mountain areas
520
- The ageing population and disabilities
190
(ii) RTD activities of a generic nature
483
(iii) Support for research infrastructures
70
Science, research and development
European Commission
Key Figures on the QoL Programme
• Over the 1999-2002 almost 10000 proposals have
been submitted to the QoL programme.
• Around 1800 hundred projects have been retained
(success rate 18%) with the participation of almost
14000 laboratories and a cost of 2.2 billion Euros.
• In addition almost 700 postdoctoral and several
hundred graduate student fellowships have been
awarded.
Science, research and development
European Commission
Highlights from FP5
• Strong networking of research activities in Europe
• Efforts on creating research cluster projects and
promoting industrial platforms
• Support to key infrastructures
• Participation of stakeholders: industry (SMEs and
large companies) and consumer organisations
• Strong training component
• Scientific support to policies (e.g. SSC)
Science, research and development
European Commission
European Network on Safety Assessment
of GM Crops www.entransfood.nl
Integrated Discussion Platform
Co-ordinating Cluster
Detection
of
unintended
effects
Gene
transfer
Review/Position Papers,
Press releases, Information
on website
Joint Work Planning
Joint production/
exchange of test materials
Common use of test facilities
Exchange of research
personnel
Training of young scientists
Science, research and development
European Commission
Structural Proteomics in Europe
EC contribution: 13.7 M€
17 partners
Training
Research
Networking
Executive Committee
Biological
Targets
viral, bacteria,
cancer, etc
Biotech
SME
Biotech
SME
Biotech
SME
Scientific Advisory
Board
Technical
Platforms
crystallisation,
X-Ray, NMR ...
 develop technologies for high throughput 3D structure
determination of +500 medically relevant proteins
Biotech
SME
Biotech
Biotech SME
SME
Science, research and development
European Commission
7 Priority Thematic Areas
Budget proposed
(EUR million)
1. Life Sciences, Genomics and Biotechnology
for Health
2. Information Society Technologies
3. Nanotechnologies, Multifunctional Materials
and New Production Systems and devices
3625
4. Aeronautics and Space
1075
5. Food Quality and Safety
6. Sustainable Development,Global Change and
Ecosystems
7. Citizens and Governance in a Knowledge Society
2255
1300
685
2120
225
Science, research and development
Priority ‘Life Sciences, Genomics and
Biotechnology for Health’
To help Europe to exploit breakthroughs in
decoding the genomes of living organisms
for the benefit of :
- public health
- citizens
- increase the competitiveness of European
biotechnology industry.
European Commission
Science, research and development
European Commission
Priority 1: Life Sciences, genomics and
biotechnology for health
Advanced genomics and its application for health
(1100 Millions Euros):
• Fundamental knowledge and basic tools for functional genomics in all
organisms
• Applications of knowledge and technologies in the field of genomics and
biotechnology for health
Combating major diseases (1155 Millions Euros):
• Application-oriented genomic approaches to medical knowledge and
technologies
• Combating cancer
• Confronting the major communicable diseases linked to poverty
Science, research and development
European Commission
Priority ‘Food Quality and Safety’
Human Being
Food/Diet
Environmental
Factors
e.g. chemicals, water, allergens
Agriculture
Fisheries
‘From Farm to Fork’  ‘From Fork to
Farm’
Science, research and development
Food Quality and Safety
 Actions envisaged:
 Epidemiology of food related diseases and genetic susceptibilities
 Impact of food on health
 Traceability processes (including GMOs)
 Methods of analysis/detection and control of chemical
contaminants and pathogenic microorganisms
 Safer production methods and healthier foodstuffs
 Impact of Animal feed on Human Health
 Environmental health risks
European Commission
Science, research and development
A wide range of instruments
 Integrated projects
 Networks of excellence
 Article 169 (joint implementation of national
programmes)
 As a “stairway of excellence”
– specific targeted research projects
– coordination actions
 Specific support actions
European Commission
Science, research and development
European Commission
Networks of Excellence: Objectives
Governing Council
European Commission
      
     

      
  

    
   
   
 

     
     
   
     
 

Scientific Council

        

 
 
 


 To
Tostructure
structurethe
theEU
EUresearch
researchpotential
potential
by integrating
existing
research
capacities
by integrating
research
capacities
Management
Group
Management Group
    
     
   


        
Funding Bodies
Representatives
Research team leader
Partner Organisation Representative
••
••
•
•
Joint
Joint research
researchactivities
activities
Integrating activities
activities
Spreading
(training)
Spreadingof
ofexcellence
excellence
Common
Common management
management


   
    
     
   
     
    
  

     
   
Science, research and development
European Commission
Integrated projects: Objectives
To integrate the critical mass of activities/resources needed for :
 addressing major societal needs
 increasing EU competitiveness
predefined S/T
results and
clear deliverables
Ethical aspects, science-society dialogue
Training
strong management
structure
RTD 4 RTD 5
RTD 3
Management
RTD 1
RTD 2
Demonstration
Technology transfer, exploitation
Implementation
Plan
Science, research and development
European Commission
Invitation to submit Expressions of Interest
AIMS:
• to identify priority topics
• to focus the call
• to avoid over-subscription
• to assist in proposal making
• to assist in consortium building
THE AIMS WERE NOT:
• to pre-assess S/T quality of a subsequent
proposal
• to pre-select a consortium or to « freeze » the
composition of a consortium
16
Science, research and development
European Commission
Expressions of Interest -Results
FP6:
 Close to 16.000 EoIs received
Priority 1:
 Close to 2.000 EoIs received
 Assessed with the help of over 200 external experts
 Proposals address 2/3 integrated projects and 1/3 networks
Priority 5:
 Close to 1.000 EoIs received
 Assessed with the help of over 85 external experts
 Proposals address 60% integrated projects and 40% networks
Science, research and development
European Commission
Analysis of Expressions of Interest
• EOI analysis performed in two stages
– remote evaluation
– panel discussion in Brussels
• Each panel was to identify research topics
– of the highest relevance to Europe and
– considered ready for implementation via a new instrument
18
Science, research and development
European Commission
Priority 1
Research topics of European strategic importance considered
ready for possible implementation via a new instrument
Total EoI
Received
Fundamental Genomics
Applied Genomics and
Biotechnology
Combating Major
Diseases
Combating Cancer
Poverty related Diseases
TOTAL
Selected Topics
523
TOTAL
30
NoE
10
IP
20
401
40*
11
20
702
33*
13
18
302
69
1997
14
10
127*
5
2
41
9
8
75
* some of which addressed by NoE and/or IP
Science, research and development
European Commission
Priority 5
Research topics of European strategic importance considered
ready for possible implementation via a new instrument
Food chain
Traceability
Impact of food on health
Epidemiology of food
related diseases and
allergies
Methods of analysis,
detection and control
Safer production
methods
Impact of animal food
Environmental health
risks
Total
TOTAL
6
2
NoE
2
1
IP
4
1
10
5
5
62
5
1
4
153
6
2
4
17
9
8
2
0
2
100
5
2
3
1008
53
22
31
96
168
429
Science, research and development
European Commission
From EOI analysis to the work
programme for the first FP6 call
• Preparation of the work programme for the first call of FP6
is based on EOI analysis but will require further focusing
due to budgetary limitations
• Preparation of the work programme will involve input from
inter-service consultations, Expert Advisory Groups and the
Programme Committee
• A conference marking the launch of the FP6 has taken place
in Brussels on November 11-13 2002
• Publication first calls for proposals in the Official Journal
expected in December 2002 (deadlines March-April 2003)
21